Diabetes mellitus in pheochromocytoma and paraganglioma: Prevalence, dynamics of insulin secretion / sensitivity and predictors of remission. Issue 6 (November 2020)
- Record Type:
- Journal Article
- Title:
- Diabetes mellitus in pheochromocytoma and paraganglioma: Prevalence, dynamics of insulin secretion / sensitivity and predictors of remission. Issue 6 (November 2020)
- Main Title:
- Diabetes mellitus in pheochromocytoma and paraganglioma: Prevalence, dynamics of insulin secretion / sensitivity and predictors of remission
- Authors:
- Khatiwada, Saurav
Agarwal, Shipra
Kandasamy, Devasenathipathy
Jyotsna, V.P.
Kumar, Rajeev
Kumar Bansal, Virinder
Pandey, R.M.
Gupta, Nandita
Tandon, Nikhil - Abstract:
- Abstract: Background and aims: Pheochromocytoma and paraganglioma (PPGL) are associated with dysglycemia and diabetes mellitus (DM) much of which improves post operatively. In this study, we set out to ascertain pre and post-operative prevalence of DM in patients with PPGL based on oral glucose tolerance test (OGTT) and HbA1c and to evaluate effect of insulin secretion and sensitivity indices on DM pre-operatively. Methods: Clinical and anthropometric data collection, HbA1c, 75 g OGTT with serum insulin estimation were done pre-operatively (n = 34) and at follow-up after successful surgery (n = 24) in patients with PPGL. Results: Pre and post-operative prevalence of DM were 48%(18/37) and 17% (4/24) respectively. Comparison of patients with highest (Q4) and lowest (Q1) quartiles of insulinogenic index (IGI), a parameter of insulin secretion, revealed trends towards higher prevalence of DM in patients with lower IGI (Q4 to Q1: 29% versus 71%, n = 28, p = 0.24)but no association was observed with HOMA-IR (Q4 to Q1:50% versus 57%, n = 28, p = 1.00), an insulin sensitivity index. DM remitted in 77% patients post-operatively, predicted by duration of DM of<3 years. Conclusion: There is high prevalence of DM in PPGL, with marked remission post-operatively, especially predicted by shorter duration of DM. Impaired insulin secretion is more strongly associated with pre-operative DM than increased insulin resistance. Highlights: Pheochromocytoma and Paraganglioma cause a reversibleAbstract: Background and aims: Pheochromocytoma and paraganglioma (PPGL) are associated with dysglycemia and diabetes mellitus (DM) much of which improves post operatively. In this study, we set out to ascertain pre and post-operative prevalence of DM in patients with PPGL based on oral glucose tolerance test (OGTT) and HbA1c and to evaluate effect of insulin secretion and sensitivity indices on DM pre-operatively. Methods: Clinical and anthropometric data collection, HbA1c, 75 g OGTT with serum insulin estimation were done pre-operatively (n = 34) and at follow-up after successful surgery (n = 24) in patients with PPGL. Results: Pre and post-operative prevalence of DM were 48%(18/37) and 17% (4/24) respectively. Comparison of patients with highest (Q4) and lowest (Q1) quartiles of insulinogenic index (IGI), a parameter of insulin secretion, revealed trends towards higher prevalence of DM in patients with lower IGI (Q4 to Q1: 29% versus 71%, n = 28, p = 0.24)but no association was observed with HOMA-IR (Q4 to Q1:50% versus 57%, n = 28, p = 1.00), an insulin sensitivity index. DM remitted in 77% patients post-operatively, predicted by duration of DM of<3 years. Conclusion: There is high prevalence of DM in PPGL, with marked remission post-operatively, especially predicted by shorter duration of DM. Impaired insulin secretion is more strongly associated with pre-operative DM than increased insulin resistance. Highlights: Pheochromocytoma and Paraganglioma cause a reversible form of diabetes mellitus. Pre-operative prevalence of diabetes was 48%, which decreased to 17% post operatively. Duration of diabetes less than three years and lower HbA1c were significantly associated with remission. Impaired insulin secretion, rather than impaired insulin sensitivity, was predominant factor. … (more)
- Is Part Of:
- Diabetes & metabolic syndrome. Volume 14:Issue 6(2020)
- Journal:
- Diabetes & metabolic syndrome
- Issue:
- Volume 14:Issue 6(2020)
- Issue Display:
- Volume 14, Issue 6 (2020)
- Year:
- 2020
- Volume:
- 14
- Issue:
- 6
- Issue Sort Value:
- 2020-0014-0006-0000
- Page Start:
- 2169
- Page End:
- 2175
- Publication Date:
- 2020-11
- Subjects:
- Pheochromocytoma -- Paraganglioma -- Diabetes mellitus -- Insulin resistance -- Insulin sensitivity
Diabetes -- Periodicals
Metabolism -- Disorders -- Periodicals
Diabetes Mellitus -- Periodicals
Metabolic Diseases -- Periodicals
Diabète -- Périodiques
Métabolisme, Troubles du -- Périodiques
Endocrinologie -- Périodiques
Diabète -- Physiopathologie -- Périodiques
Diabetes
Metabolism -- Disorders
Electronic journals
Periodicals
616.462 - Journal URLs:
- http://www.clinicalkey.com.au/dura/browse/journalIssue/18714021 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/18714021 ↗
http://www.sciencedirect.com/science/journal/18714021 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.dsx.2020.10.030 ↗
- Languages:
- English
- ISSNs:
- 1871-4021
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3579.600509
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 15370.xml